help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-0593
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kluge, M.
Right arrow Articles by Steiger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kluge, M.
Right arrow Articles by Steiger, A.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 8 3202-3205
Copyright © 2007 by The Endocrine Society

Ghrelin Suppresses Secretion of Luteinizing Hormone in Humans

Michael Kluge, Petra Schüssler, Manfred Uhr, Alexander Yassouridis and Axel Steiger

Max-Planck Institute of Psychiatry, 80804 Munich, Germany

Address all correspondence and requests for reprints to: Dr. Michael Kluge, Max-Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany. E-mail: kluge{at}mpipsykl.mpg.de.

Context: Ghrelin affects the hypothalamic-pituitary-gonadal axis in various nonhuman mammalians, predominantly by suppressing secretion of LH. However, for humans, no such evidence exists.

Objective: Our objective was to study the effect of ghrelin on secretion of LH and testosterone in humans.

Design, Participants, and Intervention: Nocturnal (2000–0700 h) secretion profiles of LH and testosterone were determined in 10 healthy males (25.7 ± 3.0 yr) twice, receiving 50 µg ghrelin or placebo at 2200, 2300, 2400, and 0100 h, in this single-blind, randomized, cross-over study.

Results: Ghrelin was associated with significantly (P < 0.05) lower mean plasma levels of both LH (2340–0200 h) and testosterone (0040–0300 h) than placebo. LH peak levels of the pulse after first administration of ghrelin/placebo were significantly (P = 0.014) smaller in the ghrelin (2.98 ± 1.34 mIU/ml) than in the placebo condition (4.37 ± 1.09 mIU/ml). In addition, the interval between this and the preceding peak was significantly (P = 0.010) longer in the ghrelin (255.8 ± 79.1 min) than in the placebo condition (190.8 ± 51.0 min). Significantly (P = 0.005) more LH pulses occurred with placebo (3.2 ± 0.75) than ghrelin (2.6 ± 0.7) subsequent to ghrelin/placebo administration.

Conclusions: Ghrelin caused both a delay and suppression of the amplitude of LH pulses. These findings are in accordance with those in nonhuman mammalians.




This article has been cited by other articles:


Home page
Hum ReprodHome page
C. I. Messini, K. Dafopoulos, N. Chalvatzas, P. Georgoulias, and I. E. Messinis
Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle
Hum. Reprod., April 1, 2009; 24(4): 976 - 981.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Lue, C. Wang, Y. Cui, X. Wang, J. Sha, Z. Zhou, J. Xu, C. Wang, A. P. Sinha Hikim, and R. S. Swerdloff
Levonorgestrel Enhances Spermatogenesis Suppression by Testosterone with Greater Alteration in Testicular Gene Expression in Men
Biol Reprod, March 1, 2009; 80(3): 484 - 492.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Misra, D. K Katzman, J. Cord, S. J Manning, D. Mickley, D. B Herzog, K. K Miller, and A. Klibanski
Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents
Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1478 - 1484.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Lanfranco, L. Bonelli, M. Baldi, E. Me, F. Broglio, and E. Ghigo
Acylated Ghrelin Inhibits Spontaneous Luteinizing Hormone Pulsatility and Responsiveness to Naloxone But Not That to Gonadotropin-Releasing Hormone in Young Men: Evidence for a Central Inhibitory Action of Ghrelin on the Gonadal Axis
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3633 - 3639.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Misra, D. K. Katzman, J. Cord, S. J. Manning, N. Mendes, D. B. Herzog, K. K. Miller, and A. Klibanski
Bone Metabolism in Adolescent Boys with Anorexia Nervosa
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3029 - 3036.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Viani, A. Vottero, F. Tassi, G. Cremonini, C. Sartori, S. Bernasconi, B. Ferrari, and L. Ghizzoni
Ghrelin Inhibits Steroid Biosynthesis by Cultured Granulosa-Lutein Cells
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1476 - 1481.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. R Vulliemoz, E. Xiao, L. Xia-Zhang, J. Rivier, and M. Ferin
Astressin B, a Nonselective Corticotropin-Releasing Hormone Receptor Antagonist, Prevents the Inhibitory Effect of Ghrelin on Luteinizing Hormone Pulse Frequency in the Ovariectomized Rhesus Monkey
Endocrinology, March 1, 2008; 149(3): 869 - 874.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society